A GENETIC-POLYMORPHISM IN COUMARIN 7-HYDROXYLATION - SEQUENCE OF THE HUMAN CYP2A GENES AND IDENTIFICATION OF VARIANT CYP2A6 ALLELES

被引:0
|
作者
FERNANDEZSALGUERO, P
HOFFMAN, SMG
CHOLERTON, S
MOHRENWEISER, H
RAUNIO, H
RAUTIO, A
PELKONEN, O
HUANG, JD
EVANS, WE
IDLE, JR
GONZALEZ, FJ
机构
[1] NCI, BETHESDA, MD 20892 USA
[2] LAWRENCE LIVERMORE NATL LAB, LIVERMORE, CA USA
[3] UNIV NEWCASTLE UPON TYNE, SCH MED, DEPT PHARMACOL SCI, NEWCASTLE UPON TYNE, TYNE & WEAR, ENGLAND
[4] UNIV OULU, DEPT PHARMACOL & TOXICOL, OULU, FINLAND
[5] NATL CHENG KUNG UNIV, DEPT PHARMACOL, TAINAN 70101, TAIWAN
[6] ST JUDE CHILDRENS RES HOSP, DEPT PHARMACEUT, MEMPHIS, TN 38105 USA
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A group of human cytochrome P450 genes encompassing the CYP2A, CYP2B, and CYP2F subfamilies were cloned and assembled into a 350-kb contig localized on the long arm of chromosome 19. Three complete CYP2A genes-CYP2A6, CYP2A7, and CYP2A13-plus two pseudogenes truncated after exon 5, were identified and sequenced, A variant CYP2A6 allele that differed from the corresponding CYP2A6 and CYP2A7 cDNAs previously sequenced was found and was designated CYP2A6v2. Sequence differences in the CYP2A6v2 gene are restricted to regions encompassing exons 3, 6, and 8, which bear sequence relatedness with the corresponding exons of the CYP2A7 gene, located downstream and centromeric of CYP2A6v2, suggesting recent gene-conversion events, The sequencing of all the CYP2A genes allowed the design of a PCR diagnostic test for the normal CYP2A6 allele, the CYP2A6v2 allele, and a variant-designated CYP2A6v1-that encodes an enzyme with a single inactivating amino acid change. These variant alleles were found in individuals who were deficient in their ability to metabolize the CYP2A6 probe drug coumarin, The allelic frequencies of CYP2A6v1 and CYP2A6v2 differed significantly between Caucasian, Asian, and African-American populations, These studies establish the existence of a new cytochrome P450 genetic polymorphism.
引用
收藏
页码:651 / 660
页数:10
相关论文
共 50 条
  • [41] CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians
    Inoue, K
    Yamazaki, H
    Shimada, T
    ARCHIVES OF TOXICOLOGY, 2000, 73 (10-11) : 532 - 539
  • [42] Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans
    Nakajima, M
    Kwon, JT
    Tanaka, N
    Zenta, T
    Yamamoto, Y
    Yamamoto, H
    Yamazaki, H
    Yamamoto, T
    Kuroiwa, Y
    Yokoi, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (01) : 72 - 78
  • [43] Pronounced differences in inhibition potency of lactone and non-lactone compounds for mouse and human coumarin 7-hydroxylases (CYP2A5 and CYP2A6)
    Juvonen, RO
    Gynther, J
    Pasanen, M
    Alhava, E
    Poso, A
    XENOBIOTICA, 2000, 30 (01) : 81 - 92
  • [44] CYP2A6 genetic polymorphism and its relation to the risk of smoking dependence in Iranian men
    Emamghoreishi, Masoumeh
    Bokaee, Hamid-Reza
    Keshavarz, Mojtaba
    PHYSIOLOGY AND PHARMACOLOGY, 2009, 12 (04): : 296 - +
  • [45] Relationship between CYP2A6 Genetic Polymorphism, as a Marker of Nicotine Metabolism, and Ulcerative Colitis
    Altarescu, Gheona
    Rachmilewitz, Daniel
    Zevin, Shoshana
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (02): : 87 - 90
  • [46] Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic populations
    Kim, Jeong-Hyun
    Cheong, Hyun Sub
    Park, Byung Lae
    Kim, Lyoung Hyo
    Shin, Hee Jung
    Na, Han Sung
    Chung, Myeon Woo
    Shin, Hyoung Doo
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (01) : 115 - 128
  • [47] Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic populations
    Jeong-Hyun Kim
    Hyun Sub Cheong
    Byung Lae Park
    Lyoung Hyo Kim
    Hee Jung Shin
    Han Sung Na
    Myeon Woo Chung
    Hyoung Doo Shin
    Archives of Pharmacal Research, 2015, 38 : 115 - 128
  • [48] Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro
    Yoshida, R
    Nakajima, M
    Nishimura, K
    Tokudome, S
    Kwon, JT
    Yokoi, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (01) : 69 - 76
  • [49] CYP2A6 polymorphism reveals differences in japan and the existence of a specific variant in ovambo and Turk populations
    Takeshita, H.
    Hieda, Y.
    Fujihara, J.
    Xue, Y.
    Nakagami, N.
    Takayama, K.
    Imamura, S.
    Kataoka, K.
    HUMAN BIOLOGY, 2006, 78 (02) : 235 - 242
  • [50] Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation
    Kumondai, Masaki
    Hosono, Hiroki
    Maekawa, Masamitsu
    Yamaguchi, Hiroaki
    Mano, Nariyasu
    Oda, Akifumi
    Hirasawa, Noriyasu
    Hiratsuka, Masahiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : 82 - 89